SHALBY

Shalby Share Price

₹204.00 -5.36 (-2.56%)

22 Feb, 2025 21:21

SIP TrendupStart SIP in SHALBY

Start SIP

Performance

  • Low
  • ₹201
  • High
  • ₹215
  • 52 Week Low
  • ₹195
  • 52 Week High
  • ₹325
  • Open Price₹208
  • Previous Close₹209
  • Volume56,967

Investment Returns

  • Over 1 Month -10.57%
  • Over 3 Month -5.44%
  • Over 6 Month -25.42%
  • Over 1 Year -30.57%
SIP Lightning

Smart Investing Starts Here Start SIP with Shalby for Steady Growth!

Invest Now

Shalby Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 66.9
  • PEG Ratio
  • -1.1
  • Market Cap Cr
  • 2,203
  • P/B Ratio
  • 2.2
  • Average True Range
  • 9.3
  • EPS
  • 3.13
  • Dividend Yield
  • 0.6
  • MACD Signal
  • -5.17
  • RSI
  • 42.17
  • MFI
  • 28.66

Shalby Financials

Shalby Technicals

EMA & SMA

Current Price
₹204.00
-5.36 (-2.56%)
pointer
  • stock-down_img
  • Bearish Moving Average 15
  • stock-up_img
  • Bullish Moving Average 1
  • 20 Day
  • ₹210.56
  • 50 Day
  • ₹219.54
  • 100 Day
  • ₹230.85
  • 200 Day
  • ₹242.46

Resistance and Support

206.49 Pivot Speed
  • R3 225.68
  • R2 220.11
  • R1 212.06
  • S1 198.44
  • S2 192.87
  • S3 184.82

What's your outlook on Shalby?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Shalby Ltd. is a leading healthcare provider in India, specializing in orthopedic care and multi-specialty services. The company operates a network of hospitals offering advanced medical treatments, focusing on patient-centric care, quality, and innovation in healthcare delivery.

Shalby has an operating revenue of Rs. 1,066.30 Cr. on a trailing 12-month basis. An annual revenue growth of 15% is outstanding, Pre-tax margin of 14% is healthy, ROE of 8% is fair but needs improvement. The company has a reasonable debt to equity of 18%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 30 which is a POOR score indicating inconsistency in earnings, a RS Rating of 37 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C which is evident from recent supply seen, Group Rank of 19 indicates it belongs to a strong industry group of Medical-Hospitals and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Shalby Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-02-03 Quarterly Results & Others To consider other business matters. per share(5%)Final Dividend
2024-10-30 Quarterly Results
2024-07-08 Quarterly Results
2024-05-28 Audited Results & Final Dividend
2024-02-07 Quarterly Results

Shalby F&O

Shalby Shareholding Pattern

74.27%
0%
4.65%
10.78%
10.3%

About Shalby

  • NSE Symbol
  • SHALBY
  • BSE Symbol
  • 540797
  • Chairman & Managing Director
  • Dr. Vikram Shah
  • ISIN
  • INE597J01018

Similar Stocks to Shalby

Shalby FAQs

Shalby share price is ₹204 As on 22 February, 2025 | 21:07

The Market Cap of Shalby is ₹2203.4 Cr As on 22 February, 2025 | 21:07

The P/E ratio of Shalby is 66.9 As on 22 February, 2025 | 21:07

The PB ratio of Shalby is 2.2 As on 22 February, 2025 | 21:07

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23